St. Petersburg, FL

St. Petersburg is our primary softgel development and manufacturing facility in North America with capacity of 18 billion capsules per year.  The featured RP Scherer softgel technology is a proven oral drug delivery solution to enhance bioavailability of poorly soluble Rx and OTC drug candidates.  Non-gelatin based OptiShell® and Vegicaps® capsules expand the range of molecules into softgel, ideal for challenging fill formulation. Within the Catalent network, we offer a broad range of integrated formulation and analytical services to solve your most difficult development and manufacturing challenges. 

Size: 329,073 ft 2

If you plan to visit our location soon, please download the  Visitor Welcome Guide  for more information.


+1 727 803 2100


2725 Scherer Drive North,
St. Petersburg, FL 33716
View on Map >


+1 727 803 1639


  • EMA/MHRA Approved
  • FDA Approved
  • PMDA
  • CFDA (China)
  • MOH (Saudi Arabia, Turkey)
  • MFDS

Sales Inquiries

Reach out to one of our experts to discuss any of our offerings or a specific solution for your project challenges.




We recognize talent is our most important asset. To explore a career with Catalent, visit our  Careers Section  to submit your resume, or contact us at